Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
| Autor: | Schadendorf, D. *, Ugurel, S., Schuler-Thurner, B., Nestle, F.O., Enk, A., Bröcker, E.-B., Grabbe, S., Rittgen, W., Edler, L., Sucker, A., Zimpfer-Rechner, C., Berger, T., Kamarashev, J., Burg, G., Jonuleit, H., Tüttenberg, A., Becker, J.C., Keikavoussi, P., Kämpgen, E., Schuler, G. |
|---|---|
| Zdroj: | In Annals of Oncology April 2006 17(4):563-570 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|